Although the non-CD117+CD44+CSC and the SKOV3 cell vaccines showed marked efficacy against ovarian cancer as well, this efficacy was actually more efficient in the mice immunized with the CD117+CD44+CSC vaccine. The gene discussed is KIT; the disease is ovarian cancer.